ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 88 filers reported holding ADURO BIOTECH INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $38,383 | -61.3% | 24,924 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $99,198 | -39.9% | 24,924 | +11.0% | 0.00% | -33.3% |
| Q3 2018 | $165,052 | -99.9% | 22,456 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $157,192,000 | +13.0% | 22,456 | +50.1% | 0.00% | +50.0% |
| Q1 2018 | $139,147,000 | +144844.8% | 14,962 | +17.1% | 0.00% | +100.0% |
| Q4 2017 | $96,000 | -66.6% | 12,781 | -52.6% | 0.00% | -50.0% |
| Q3 2017 | $287,000 | -6.5% | 26,961 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $307,000 | +5.9% | 26,961 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $290,000 | -7.9% | 26,961 | -2.3% | 0.00% | 0.0% |
| Q4 2016 | $315,000 | -8.2% | 27,607 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $343,000 | +9.9% | 27,607 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $312,000 | +67.7% | 27,607 | +316.6% | 0.00% | +100.0% |
| Q4 2015 | $186,000 | -21.8% | 6,627 | -15.5% | 0.00% | -50.0% |
| Q2 2015 | $238,000 | – | 7,844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 745,886 | $8,503,000 | 1.71% |
| OAK RIDGE INVESTMENTS LLC | 915,134 | $10,433,000 | 0.34% |
| Rock Springs Capital Management LP | 415,000 | $4,731,000 | 0.32% |
| CLOUGH CAPITAL PARTNERS L P | 326,400 | $3,721,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $608,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 36,200 | $413,000 | 0.10% |
| Vident Investment Advisory, LLC | 65,874 | $751,000 | 0.09% |
| Virtus ETF Advisers LLC | 23,109 | $263,000 | 0.08% |
| Foundry Partners, LLC | 77,452 | $883,000 | 0.04% |
| Artal Group S.A. | 100,000 | $1,140,000 | 0.02% |